Opinion: Don’t let bureaucracy constrict the supply of Covid-19 vaccines
Vaccination, particularly for the most vulnerable Americans, is the surest way for us to overcome the Covid-19 crisis. As physicians, we celebrate the light at the end of the tunnel, in large part due to Operation Warp Speed. But as members of Congress, we are becoming increasingly concerned that federal bureaucracy continues to stand in the way of rapid, widespread administration of Covid-19 vaccines.
The nation has gained a tremendous amount of knowledge about Covid-19 over the past year. Similarly, over the past few weeks, the scientific community has published encouraging analyses about the vaccines that are playing a starring role in leading us out of this crisis. Mountains of real-world evidence are showing that the two mRNA vaccines authorized by the FDA — the first made by Pfizer and BioNTech, the other by Moderna, both of which are supposed to be administered as a two-dose regimen — will provide substantial protection against Covid-19 even after only one dose.
Read Original Article: Opinion: Don’t let bureaucracy constrict the supply of Covid-19 vaccines »
